Results 41 to 50 of about 53,338 (196)

A Trypanosoma cruzi Genome Tandem Repetitive Satellite DNA Sequence as a Molecular Marker for a LAMP Assay for Diagnosing Chagas’ Disease

open access: yesDisease Markers, Volume 2020, Issue 1, 2020., 2020
Chagas’ disease is a neglected tropical disease caused by Trypanosoma cruzi which is endemic throughout Latin America and is spread by worldwide migration. Diagnosis is currently limited to serological and molecular techniques having variations regarding their sensitivity and specificity.
Diego Ordóñez   +11 more
wiley   +1 more source

Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi

open access: yesMemorias do Instituto Oswaldo Cruz, 2012
In this study the effect of eight DNA topoisomerase inhibitors on the growth Trypanosoma rangeli epimastigotes in cell culture was investigated. Among the eight compounds tested, idarubicin was the only compound that displayed promising trypanocidal ...
Momodou Jobe   +14 more
doaj   +1 more source

Differential expression and activity of arginine kinase between the American trypanosomatids Trypanosoma rangeli and Trypanosoma cruzi.

open access: yesExperimental parasitology, 2021
Trypanosoma rangeli is a non-virulent hemoflagellate parasite infecting humans, wild and domestic mammals in Central and Latin America. The share of genotypic, phenotypic, and biological similarities with the virulent, human-infective T.
C. L. Mansur Pontes   +6 more
semanticscholar   +1 more source

Trypanosoma rangeli and Trypanosoma cruzi: cross-reaction among their immunogenic components [PDF]

open access: yesMemórias do Instituto Oswaldo Cruz, 1996
It has been demonstrated that immuno-modu-lating mechanisms induced by epimastigotes ofTrypanosoma rangeli, an assumed harmless hu-man parasite, may have relevance to protectionagainst Trypanosoma cruzi, the causative organ-ism of Chagas’ disease (B Basso et al. 1991 Am JTrop Med Hyg 44: 413-419).
A. Saldaña, O. E. Sousa
openaire   +4 more sources

In Silico Identification of New Targets for Diagnosis, Vaccine, and Drug Candidates against Trypanosoma cruzi

open access: yesDisease Markers, Volume 2020, Issue 1, 2020., 2020
Chagas disease is a neglected tropical disease caused by the parasite Trypanosoma cruzi. Despite the efforts and distinct methodologies, the search of antigens for diagnosis, vaccine, and drug targets for the disease is still needed. The present study is aimed at identifying possible antigens that could be used for diagnosis, vaccine, and drugs targets
Rafael Obata Trevisan   +17 more
wiley   +1 more source

Studies on Trypanosoma rangeli Tejera, 1920: V - Developmental pattern in the alimentary canal of Rhodnius prolixus

open access: yesMemorias do Instituto Oswaldo Cruz, 1983
The morphological sequence of Trypanosoma rangeli development in the alimentary canal of Rhodnius prolixus, is described, with observation made in dissected guts from 6 hours to 45 days post-infection.
N. Añez
doaj   +1 more source

Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection

open access: yesMemorias do Instituto Oswaldo Cruz, 2008
In our laboratory, we have developed a model of vaccination in mice with Trypanosoma rangeli, a non-pathogenic parasite that shares many antigens with Trypanosoma cruzi. The vaccinated mice were protected against infection with virulent T. cruzi.
Beatriz Basso   +2 more
doaj   +1 more source

Karyotype variability in Trypanosoma rangeli

open access: yesParasitology, 1996
SUMMARYThe molecular karyotypes of several different protozoan parasites show high intra-species variation, including different kinetoplastids such as Trypanosoma brucei, Trypanosoma cruzi and Leishmania ssp. In this study, the molecular karyotype of Trypanosoma rangeli was examined.
Henriksson, J.   +4 more
openaire   +2 more sources

La región intergénica del gen H2A apoya las subpoblaciones KP1(-) y KP1(+) de Trypanosoma rangeli

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2007
Introducción. Con base en la amplificación del ADN de los minicírculos del cinetoplasto y de los genes miniexón, Trypanosoma rangeli ha sido clasificado en las subpoblaciones KP1(-) y KP1(+). Objetivo.
Brian Alejandro Suárez   +2 more
doaj   +1 more source

Salivaria or Stercoraria? The Trypanosoma rangelidilemma [PDF]

open access: yesKinetoplastid Biology and Disease, 2002
The taxonomic status of Trypanosoma rangeli as well as the tools for its molecular characterization is briefly commented.
openaire   +2 more sources

Home - About - Disclaimer - Privacy